2-Butynoic acid → HCID 86720321, compound
Reaction equation
[NH2:1][C:2]1[C:3]2[N:4]([C:8]([C@@H:26]([NH2:28])[CH3:27])=[N:9][C:10]=2[C:11]2[CH:25]=[CH:24][C:14]([C:15]([NH:17][C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][N:19]=3)=[O:16])=[CH:13][CH:12]=2)[CH:5]=[CH:6][N:7]=1.[C:29](O)(=[O:33])[C:30]#[C:31][CH3:32]>>[NH2:1][C:2]1[C:3]2[N:4]([C:8]([C@@H:26]([NH:28][C:29](=[O:33])[C:30]#[C:31][CH3:32])[CH3:27])=[N:9][C:10]=2[C:11]2[CH:25]=[CH:24][C:14]([C:15]([NH:17][C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][N:19]=3)=[O:16])=[CH:13][CH:12]=2)[CH:5]=[CH:6][N:7]=1Participants
3
Procedure
This compound was prepared, in an analogous manner as described in Example 2, from (S)-4-(8-amino-3-(1-aminoethyl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide (intermediate 45) and 2-butynoic acid, to afford the title compound (9.5 mg, 26.9%). Data: UPLC(C) Rt: 1.38 min; m/z 440.3 (M+H)+.
Workup
- customThis compound was prepared, in an analogous manner
Sources & evidence
- ORD record
- ord-ab22608c25ef44afab89244f2ed34370
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09290504B2
Reaction notes
Loading…